148 related articles for article (PubMed ID: 24817936)
1. NCAM and FGFR1 coexpression and colocalization in renal tumors.
Ćirović S; Vještica J; Mueller CA; Tatić S; Vasiljević J; Milenković S; Mueller GA; Marković-Lipkovski J
Int J Clin Exp Pathol; 2014; 7(4):1402-14. PubMed ID: 24817936
[TBL] [Abstract][Full Text] [Related]
2. Expression of neural cell adhesion molecule in renal cell carcinoma.
Cirović SL; Cegar BS; Vjestica JM; Dundjerović DM; Stojanović MM; Vuksanović AM; Mitrović DB; Lazić MD; Tulić CD; Marković-Lipkovski JZ
Acta Chir Iugosl; 2012; 59(1):39-44. PubMed ID: 22924301
[TBL] [Abstract][Full Text] [Related]
3. DOG1, cyclin D1, CK7, CD117 and vimentin are useful immunohistochemical markers in distinguishing chromophobe renal cell carcinoma from clear cell renal cell carcinoma and renal oncocytoma.
Zhao W; Tian B; Wu C; Peng Y; Wang H; Gu WL; Gao FH
Pathol Res Pract; 2015 Apr; 211(4):303-7. PubMed ID: 25596994
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma.
Tsimafeyeu I; Demidov L; Stepanova E; Wynn N; Ta H
Scand J Urol Nephrol; 2011 Apr; 45(3):190-5. PubMed ID: 21329481
[TBL] [Abstract][Full Text] [Related]
5. Modulation of NCAM/FGFR1 signaling suppresses EMT program in human proximal tubular epithelial cells.
Životić M; Tampe B; Müller G; Müller C; Lipkovski A; Xu X; Nyamsuren G; Zeisberg M; Marković-Lipkovski J
PLoS One; 2018; 13(11):e0206786. PubMed ID: 30383875
[TBL] [Abstract][Full Text] [Related]
6. Variable Expression of Neural Cell Adhesion Molecule Isoforms in Renal Tissue: Possible Role in Incipient Renal Fibrosis.
Marković-Lipkovski J; Životić M; Müller CA; Tampe B; Ćirović S; Vještica J; Tomanović N; Zeisberg M; Müller GA
PLoS One; 2015; 10(9):e0137028. PubMed ID: 26327314
[TBL] [Abstract][Full Text] [Related]
7. FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry.
Tong K; Hu Z
Virchows Arch; 2021 Apr; 478(4):647-658. PubMed ID: 32812119
[TBL] [Abstract][Full Text] [Related]
8. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
9. NCAM-mimetic, FGL peptide, restores disrupted fibroblast growth factor receptor (FGFR) phosphorylation and FGFR mediated signaling in neural cell adhesion molecule (NCAM)-deficient mice.
Aonurm-Helm A; Berezin V; Bock E; Zharkovsky A
Brain Res; 2010 Jan; 1309():1-8. PubMed ID: 19909731
[TBL] [Abstract][Full Text] [Related]
10. Number and brightness analysis reveals that NCAM and FGF2 elicit different assembly and dynamics of FGFR1 in live cells.
Zamai M; Trullo A; Giordano M; Corti V; Arza Cuesta E; Francavilla C; Cavallaro U; Caiolfa VR
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30478195
[TBL] [Abstract][Full Text] [Related]
11. NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.
Takase N; Koma Y; Urakawa N; Nishio M; Arai N; Akiyama H; Shigeoka M; Kakeji Y; Yokozaki H
Cancer Lett; 2016 Sep; 380(1):47-58. PubMed ID: 27317650
[TBL] [Abstract][Full Text] [Related]
12. Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior.
Daniel L; Bouvier C; Chetaille B; Gouvernet J; Luccioni A; Rossi D; Lechevallier E; Muracciole X; Coulange C; Figarella-Branger D
Hum Pathol; 2003 Jun; 34(6):528-32. PubMed ID: 12827605
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
14. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking.
Francavilla C; Cattaneo P; Berezin V; Bock E; Ami D; de Marco A; Christofori G; Cavallaro U
J Cell Biol; 2009 Dec; 187(7):1101-16. PubMed ID: 20038681
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
16. Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?
Horstmann M; Geiger LM; Vogel U; Schmid H; Hennenlotter J; Kuehs U; Merseburger AS; Kruck S; Stenzl A; Bedke J
World J Urol; 2012 Aug; 30(4):525-31. PubMed ID: 21928123
[TBL] [Abstract][Full Text] [Related]
17. FGFR1 is associated with c-MYC and proangiogenic molecules in metastatic renal cell carcinoma under anti-angiogenic therapy.
Park JY; Kim PJ; Shin SJ; Lee JL; Cho YM; Go H
Histopathology; 2020 May; 76(6):838-851. PubMed ID: 31990416
[TBL] [Abstract][Full Text] [Related]
18. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
19. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
[TBL] [Abstract][Full Text] [Related]
20. [Expression of cadherin17 in metanephric adenoma and its value in differential diagnosis].
Wang X; Wu N; Yang WR; Shi SS; Ma HH; Wei X; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2016 Jul; 45(7):457-61. PubMed ID: 27430690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
